GlaxoSmithKline (NYSE: GSK) reported Q1 EPS of $0.42, $0.49 worse than the analyst estimate of $0.91. Revenue for the quarter came in at $10.49 million versus the consensus estimate of $10.88 million.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

Earnings